Skip to main content
. 2020 Oct 6;21:691. doi: 10.1186/s12864-020-07104-w

Fig. 5.

Fig. 5

The novel nomogram validation. a, AUC of risk signature, TMN-stage and hypoxia score in ROC analysis were calculated at 5-year survival time. b, AUC of risk signature in ROC analysis were calculated at 1-, 3- and 5-years survival time. c, Calibration curves of risk signature used for evaluating the 3- and 5- year AUC